학술논문
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Document Type
Abstract
Author
Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia; Celsa, Ciro; Manfredi, Giulia; Nishida, Naoshi; Schoenlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U.; Weinmann, Arndt; Galle, Peter R.; Bettinger, Dominik; Lin, Chun-yen; Vogel, Arndt; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Zanuso, Valentina; Pressiani, Tiziana; Cabibbo, Giuseppe; Dalbeni, Andrea; Pinter, Matthias; Singal, Amit; Chon, Hong Jae; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J.; Sharma, Rohini
Source
In Journal of Hepatology June 2024 80 Supplement 1:S443-S443
Subject
Language
ISSN
0168-8278